Cognizin® Citicoline Increases Brain Energy (ATP) by 14% and Speeds up Formation of Brain Membranes by 26% in Healthy Adults
These findings underscore the region-specific nature of Citicoline-induced changes in brain neurochemistry, implying that oral administration of Citicoline enhances the cellular bioenergetics of the anterior cingulate cortex. This discovery holds significant significance, as preserving levels of PCr and beta NTP has been associated with neuroprotective effects.*
Cognizin® Citicoline Improves Overall Memory and Episodic Memory in Healthy Older Adults
As documented in a research article featured in The Journal of Nutrition, the consumption of Cognizin® citicoline as a dietary supplement for a duration of 12 weeks exhibited notable enhancements in memory performance among both healthy older men and women experiencing age-associated memory impairment (AAMI), with a particular emphasis on episodic memory.*
Improved Attentional Performance Following Citicoline Administration in Healthy Adult Women
Citicoline showed significantly better ability to produce correct responses on the CPT-II, likely due to improved cognitive inhibition. Our findings suggest that citicoline may improve attentional performance in middle-aged women and may ameliorate attentional deficits associated with central nervous system disorders.*
The FDA has not conducted evaluations on these statements. These items are not designed with the purpose of diagnosing, treating, or curing any illness. These declarations are intended for professionals in the field and are not intended for general consumers
SaBio Therapeutics
Copyright © 2024 SaBio Therapeutics - All Rights Reserved.